Market Cap

Human Stem Cells Institute PJSC Market Capitalization:

₽6.92 Billion

RUB as of July 1, 2024

US$77.7 Million

business Human Stem Cells Institute PJSC Company Profile

Human Stem Cells Institute PJSC Main Stock Listing

MOEX: ISKJ

Market Capitalization History of Human Stem Cells Institute PJSC

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Human Stem Cells Institute PJSC market cap

Date Market Cap YoY Change
Jan. 1, 2024 ₽8.80 B 72.98%
Jan. 1, 2023 ₽5.09 B -29.73%
Jan. 1, 2022 ₽7.24 B 161.14%
Jan. 1, 2021 ₽2.77 B 155.10%
Jan. 1, 2020 ₽1.09 B 76.07%
Jan. 1, 2019 ₽617.0 M -20.75%
Jan. 1, 2018 ₽778.6 M -39.08%
Jan. 1, 2017 ₽1.28 B 20.00%
Jan. 1, 2016 ₽1.07 B 50.26%
Jan. 1, 2015 ₽708.8 M -44.86%
Jan. 1, 2014 ₽1.29 B 34.31%
Jan. 1, 2013 ₽957.1 M -2.69%
Jan. 1, 2012 ₽983.5 M 2.61%
Jan. 1, 2011 ₽958.6 M -18.44%
Jan. 1, 2010 ₽1.18 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Human Stem Cells Institute PJSC Categories

Russia languages Healthcare languages Biotechnology
Russia Healthcare Russia Biotechnology

Stocks & Indices

Human Stem Cells Institute PJSC has the following listings and related stock indices.


Stock: MOEX: ISKJ

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.